TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 6 | 0 | 5 | 47 | 0 | 0 | 19 |
| P | %wins | 100 | 100 | 100 | 100 | 100 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/18/21 15:19 | 5/14/21 | TLIS | Talis Biomedical Corp | DE | Electr | LabEq | Laboratory Analytical Instrum | Scott Randal W. | CA | D | P.m | 203 | 10.13 | 0 | 20 | 1 | 1,723 | D | |||||||||||||||
2/19/21 18:18 | 2/17/21 | TLIS | Talis Biomedical Corp | DE | Electr | LabEq | Laboratory Analytical Instrum | Scott Randal W. | CA | D | P.d | 5,000 | 16.00 | 0 | 313 | 22 | 1,703 | I | |||||||||||||||
2/18/21 18:21 | 2/17/21 | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Scott Randal W. | CA | D | P | 1,000 | 62.50 | 0 | 16 | 320 | 21 | D | |||||||||||||||
4/2/18 16:05 | 4/2/18 | NVTA | Invitae Corp | DE | Health | Health | Medical Laboratories | Scott Randal W | CA | DO | Exec CB | P | 200 | 4.50 | 0 | 44 | 1 | 3,551 | I | ||||||||||||||
11/22/16 18:07 | 11/22/16 | NVTA | Invitae Corp | DE | Health | Health | Medical Laboratories | Scott Randal W | CA | DOT | CB,CEO | P | 400 | 6.00 | 4 | 67 | 2 | 3,506 | D | -2 | -26 | -22 | -12 | -8 | -26 | -2 | 6 | 0 | 5 | 47 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |